Neuraxis, Inc (NRXS): Total Assets

Annual figures by period end, from SEC filings.

$6.40M
As of 2025-12-31
$10.00M
As of 2026-06-30
+62.9%
3-year compound annual growth
2022-12-31: $1.48M2023-09-30: $1.24M2023-12-31: $509.5K2024-12-31: $4.76M2025-12-31: $6.40M$6.40M
2022-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$6.40M+34.6%2026-03-19, Balance as of period end
2024-12-31$4.76M+833.8%2026-03-19, Balance as of period end
2023-12-31$509.5Kn/a2025-03-20, Balance as of period end
2023-09-30$1.24Mn/a2024-04-16, Balance as of period end
2022-12-31$1.48Mn/a2024-04-16, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Neuraxis, Inc (NRXS)2025-12-31$6.40M+34.6%
ADM Tronics Unlimited, Inc. (ADMT)2026-03-31$1.83M-14.2%
Hongchang International Co., Ltd (HCIL)2024-12-31$57.45M+14.4%
Nuwellis, Inc. (NUWE)2025-12-31$6.12M-38.0%
Escalon Medical Corp (ESMC)2025-06-30$4.99M+4.9%
CapsoVision, Inc (CV)2025-12-31$18.16M+8.1%
Hyperfine, Inc. (HYPR)2025-12-31$55.26M-6.2%
Guided Therapeutics Inc (GTHP)2025-12-31$1.32M-3.9%
QT Imaging Holdings, Inc. (QTI)2025-12-31$23.02M+278.2%

Compare NRXS, ADMT, HCIL, NUWE side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗